Antimicrobial Agents — MCQs

A 30-year-old male patient presents with a painful skin rash. Despite antiviral and analgesic treatment, his symptoms have not improved. Viral strains isolated from the patient lack viral phosphorylating enzymes. Which of the following drugs is most likely to be effective in treating this condition?

Q108Easy

What is the mechanism of action of fluoroquinolones?

Q109Medium

Which of the following cephalosporins has activity against methicillin-resistant Staphylococcus aureus?

Q110Medium

Which of the following statements is not true regarding sulfonamides?

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 101: Which of the following adverse effects is most likely to occur with sulfonamides?

A. Neurologic effects including headache, dizziness, and lethargy
B. Hematuria
C. Fanconi's anemia
D. Skin reactions (Correct Answer)

Explanation: **Explanation:** **Sulfonamides** are structural analogs of PABA that inhibit dihydropteroate synthase. Their adverse effect profile is a high-yield topic for NEET-PG, with **hypersensitivity reactions** being the most frequent complication. 1. **Why Skin Reactions are Correct:** Skin reactions are the most common adverse effect of sulfonamides, ranging from mild rashes, urticaria, and photosensitivity to life-threatening conditions like **Stevens-Johnson Syndrome (SJS)** and **Toxic Epidermal Necrolysis (TEN)**. These are Type IV hypersensitivity reactions caused by the accumulation of reactive metabolites (hydroxylamines) in the skin. 2. **Analysis of Incorrect Options:** * **Neurologic effects (A):** While possible, these are rare and not the "most likely" or characteristic side effect compared to dermatological issues. * **Hematuria (B):** Sulfonamides can cause **crystalluria** (precipitation of the drug in acidic urine), which may lead to hematuria. However, this is largely prevented in modern practice by maintaining adequate hydration and urinary alkalinization, making it less common than skin reactions. * **Fanconi’s Anemia (C):** This is a genetic DNA repair defect. Sulfonamides do not cause Fanconi’s anemia, though they can cause **Aplastic Anemia** (rare) or **Hemolytic Anemia** specifically in patients with **G6PD deficiency**. **High-Yield Clinical Pearls for NEET-PG:** * **Kernicterus:** Sulfonamides displace bilirubin from albumin; they are contraindicated in newborns and near-term pregnancy. * **G6PD Deficiency:** Always remember the "Sulfas" (Sulfonamides, Sulfonylureas, Dapsone) as triggers for hemolysis. * **Drug Interactions:** They displace warfarin and phenytoin from plasma proteins, increasing their toxicity. * **Triple Sulfas:** Used historically to increase solubility and decrease the risk of crystalluria.

Question 102: Ganciclovir is preferred over acyclovir in which of the following conditions?

A. Herpes simplex keratitis
B. Herpes zoster
C. Chickenpox
D. Cytomegalovirus retinitis in AIDS patients (Correct Answer)

Explanation: **Explanation:** **1. Why Option D is Correct:** Ganciclovir is a synthetic analog of 2'-deoxyguanosine. While it shares a similar mechanism with acyclovir (inhibition of viral DNA polymerase), it is **10 to 100 times more potent against Cytomegalovirus (CMV)**. In CMV-infected cells, ganciclovir is monophosphorylated by a viral protein kinase called **UL97**, which allows it to reach much higher intracellular concentrations than acyclovir. Therefore, it is the drug of choice for life- or sight-threatening CMV infections, such as **CMV retinitis** in immunocompromised (AIDS) patients. **2. Why Other Options are Incorrect:** * **A, B, and C:** These conditions are caused by the Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV). **Acyclovir** is the preferred agent for these because it is highly effective and has a superior safety profile. Ganciclovir is significantly more toxic (causing bone marrow suppression) and is generally reserved for CMV, where acyclovir is ineffective. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Resistance:** Resistance to ganciclovir occurs due to mutations in the **UL97 gene** (preventing phosphorylation) or the viral DNA polymerase. * **Dose-Limiting Toxicity:** The most common side effect is **bone marrow suppression** (neutropenia and thrombocytopenia). This is additive if used with Zidovudine (AZT). * **Valganciclovir:** This is the L-valyl ester (prodrug) of ganciclovir with high oral bioavailability, often used for maintenance therapy in CMV retinitis. * **Foscarnet:** Used as a second-line agent for ganciclovir-resistant CMV; it does not require phosphorylation by viral kinases.

Question 103: Which aminoglycoside has the least toxic effect?

A. Ethambutol
B. Isoniazid
C. Streptomycin (Correct Answer)
D. Kanamycin

Explanation: **Explanation:** The correct answer is **Streptomycin**. Among the aminoglycosides listed, Streptomycin is considered the least toxic, particularly regarding its systemic side effect profile compared to older or more potent aminoglycosides like Kanamycin. **1. Why Streptomycin is correct:** Aminoglycosides are known for their "Big Three" toxicities: Ototoxicity, Nephrotoxicity, and Neuromuscular blockade. While all aminoglycosides carry these risks, Streptomycin is primarily **vestibulotoxic** rather than cochleotoxic or highly nephrotoxic. In clinical practice, especially within the RNTCP (tuberculosis) guidelines, it is tolerated relatively well compared to Kanamycin, which has a significantly higher incidence of permanent hearing loss and renal impairment. **2. Why the other options are incorrect:** * **Ethambutol:** This is not an aminoglycoside; it is an antimetabolite used in TB treatment. Its primary toxicity is optic neuritis. * **Isoniazid:** This is not an aminoglycoside; it is a prodrug that inhibits mycolic acid synthesis. Its primary toxicities are peripheral neuropathy and hepatitis. * **Kanamycin:** This is one of the most toxic aminoglycosides. It is highly **cochleotoxic** and **nephrotoxic**, which is why its clinical use has been largely superseded by Amikacin or Gentamicin. **3. NEET-PG High-Yield Pearls:** * **Most Nephrotoxic:** Neomycin (hence used only topically or orally for bowel prep). * **Most Ototoxic (Cochlear):** Kanamycin, Amikacin, Neomycin. * **Most Vestibulotoxic:** Streptomycin and Gentamicin. * **Mechanism of Action:** Irreversible inhibition of the 30S ribosomal subunit (bactericidal). * **Resistance Mechanism:** The most common method is the production of bacterial **inactivating enzymes** (adenylylation, acetylation, or phosphorylation).

Question 104: All of the following statements about Penicillin Resistance are true, EXCEPT:

A. Beta-lactamase production is the most common mechanism of resistance.
B. Alteration in target PBPs is an important resistance mechanism in Gram-negative bacteria. (Correct Answer)
C. Alteration in permeability/penetration of antibiotic causes resistance only in Gram-negative bacteria.
D. Beta-lactamase production causes resistance in both Gram-positive and Gram-negative bacteria.

Explanation: ### Explanation **1. Why Option B is the Correct Answer (The False Statement):** In medical pharmacology, **alteration of Penicillin-Binding Proteins (PBPs)** is the hallmark resistance mechanism for **Gram-positive bacteria**, most notably *Streptococcus pneumoniae* and *Staphylococcus aureus* (MRSA). While Gram-negative bacteria primarily rely on beta-lactamase production and porin channel mutations, the structural modification of the target site (PBPs) is the definitive mechanism that renders Gram-positive organisms resistant to almost all beta-lactams. **2. Analysis of Other Options:** * **Option A:** Correct. **Beta-lactamase production** is indeed the most prevalent and clinically significant mechanism of resistance across the bacterial spectrum. * **Option C:** Correct. Gram-negative bacteria possess an **outer lipopolysaccharide membrane** with porin channels. Resistance via decreased permeability (porin mutation/loss) is unique to Gram-negatives because Gram-positive bacteria lack this outer membrane. * **Option D:** Correct. Beta-lactamases are produced by both groups; however, Gram-positives (like *S. aureus*) secrete them extracellularly, while Gram-negatives (like *E. coli*) retain them in the **periplasmic space**, making them more efficient at lower concentrations. **3. NEET-PG High-Yield Clinical Pearls:** * **MRSA Mechanism:** Resistance in Methicillin-resistant *S. aureus* is due to the **mecA gene**, which encodes a modified PBP called **PBP2a**, which has a low affinity for beta-lactams. * **Efflux Pumps:** Another mechanism seen primarily in Gram-negatives (e.g., *Pseudomonas*) where the drug is actively pumped out. * **Vancomycin Resistance:** Unlike penicillins, Vancomycin resistance (VRSA/VRE) occurs due to a change in the target peptide from **D-Ala-D-Ala to D-Ala-D-Lac**.

Question 105: What is the mechanism of action of Delamanid?

A. Inhibition of DNA Gyrase
B. Inhibition of Alanine Racemase
C. Inhibition of Mycolic acid synthesis (Correct Answer)
D. Inhibition of Topoisomerase

Explanation: **Explanation:** **Delamanid** is a newer anti-tubercular drug belonging to the **nitrodihydro-imidazooxazole** class. It is specifically used for the treatment of Multidrug-Resistant Tuberculosis (MDR-TB). **1. Why Option C is Correct:** Delamanid acts as a prodrug that is activated by the mycobacterial enzyme **deazaflavin-dependent nitroreductase (Ddn)**. Once activated, it inhibits the synthesis of **methoxy-mycolic and keto-mycolic acids**, which are essential components of the mycobacterial cell wall. By disrupting the cell wall integrity, it exerts a potent bactericidal effect against both intra- and extracellular *Mycobacterium tuberculosis*. **2. Why Other Options are Incorrect:** * **Option A & D (DNA Gyrase/Topoisomerase):** These are the targets of **Fluoroquinolones** (e.g., Moxifloxacin, Levofloxacin). They inhibit DNA replication by preventing the relaxation of supercoiled DNA. * **Option B (Alanine Racemase):** This is the mechanism of action of **Cycloserine**, a second-line anti-tubercular drug that inhibits cell wall synthesis by preventing the incorporation of D-alanine into the peptidoglycan pentapeptide. **Clinical Pearls for NEET-PG:** * **Bedaquiline vs. Delamanid:** While both are used for MDR-TB, Bedaquiline inhibits **ATP synthase**, whereas Delamanid inhibits **mycolic acid synthesis**. * **Adverse Effect:** The most significant side effect of Delamanid is **QT interval prolongation**. Caution is required when co-administering it with other QT-prolonging drugs like Bedaquiline or Fluoroquinolones. * **Metabolism:** Unlike many TB drugs, Delamanid is primarily metabolized by **albumin** (hydrolysis) rather than Cytochrome P450 enzymes, reducing the risk of certain drug-drug interactions.

Question 106: IV Metronidazole is used in the treatment of which of the following?

A. Pseudomembranous enterocolitis
B. Anaerobic bacterial infection
C. Amoebiasis
D. All of the above (Correct Answer)

Explanation: **Explanation:** Metronidazole is a nitroimidazole derivative that acts by inhibiting DNA synthesis in anaerobic environments. It is the drug of choice for a wide range of anaerobic and protozoal infections. **Why "All of the above" is correct:** 1. **Pseudomembranous enterocolitis:** Caused by *Clostridioides difficile*, Metronidazole (IV or Oral) was traditionally the first-line treatment. While oral Vancomycin or Fidaxomicin are now preferred for initial episodes, IV Metronidazole remains a critical component in treating **severe/fulminant cases** (often combined with Vancomycin). 2. **Anaerobic bacterial infections:** Metronidazole is highly effective against Gram-negative anaerobes like *Bacteroides fragilis* and Gram-positive anaerobes like *Clostridium* species. It is used for intra-abdominal infections, brain abscesses, and aspiration pneumonia. 3. **Amoebiasis:** It is the drug of choice for invasive intestinal and extra-intestinal (liver abscess) amoebiasis caused by *Entamoeba histolytica*. In severe cases where oral intake is not possible, the IV route is utilized. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** It acts as an electron sink; its nitro group is reduced by the **pyruvate:ferredoxin oxidoreductase (PFOR)** system in anaerobes, creating toxic free radicals that cause DNA strand breakage. * **Disulfiram-like reaction:** Patients must avoid alcohol during and for 48 hours after treatment due to the inhibition of aldehyde dehydrogenase. * **Side Effects:** Metallic taste (most common), peripheral neuropathy (long-term use), and seizures. * **Drug of Choice for:** Trichomoniasis, Giardiasis, and Bacterial Vaginosis. * **Note:** It has **no activity** against aerobic bacteria.

Question 107: A 30-year-old male patient presents with a painful skin rash. Despite antiviral and analgesic treatment, his symptoms have not improved. Viral strains isolated from the patient lack viral phosphorylating enzymes. Which of the following drugs is most likely to be effective in treating this condition?

A. Acyclovir
B. Ganciclovir
C. Famciclovir
D. Foscarnet (Correct Answer)

Explanation: ### Explanation The correct answer is **D. Foscarnet**. **Mechanism and Rationale:** The clinical scenario describes a viral infection (likely Herpes Simplex or Varicella-Zoster) resistant to standard therapy due to the absence of **viral phosphorylating enzymes** (e.g., **Thymidine Kinase** in HSV/VZV or UL97 kinase in CMV). Drugs like Acyclovir, Ganciclovir, and Famciclovir are **nucleoside analogs**. They are "prodrugs" that require a three-step phosphorylation to become active. The crucial first step is mediated by the viral enzyme (Thymidine Kinase). If the virus lacks this enzyme, these drugs cannot be converted into their active monophosphate form, leading to resistance. **Foscarnet** is a pyrophosphate analog that directly inhibits viral DNA polymerase by binding to the pyrophosphate-binding site. Crucially, it **does not require activation by viral kinases**. Therefore, it remains effective against strains that are deficient in or have mutated thymidine kinase. **Analysis of Incorrect Options:** * **A, B, and C (Acyclovir, Ganciclovir, Famciclovir):** All these agents are nucleoside analogs that require initial phosphorylation by viral-specific enzymes. In the absence of these enzymes, these drugs remain inactive and ineffective. **High-Yield NEET-PG Pearls:** * **Cidofovir** is another drug that bypasses the need for viral kinase (it is a nucleotide analog already containing a phosphate group), but it still requires host cellular kinases. * **Foscarnet Side Effects:** The most common dose-limiting toxicity is **nephrotoxicity**. It is also notorious for causing **electrolyte imbalances** (hypocalcemia, hypomagnesemia, and hypokalemia) and genital ulcerations. * **Drug of Choice:** Foscarnet is the drug of choice for **Acyclovir-resistant HSV/VZV** and **Ganciclovir-resistant CMV**.

Question 108: What is the mechanism of action of fluoroquinolones?

A. Inhibits cell wall synthesis
B. Inhibits protein synthesis
C. Inhibits DNA gyrase (Correct Answer)
D. Interferes with intermediary metabolism

Explanation: **Explanation:** Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin) are bactericidal antibiotics that primarily target bacterial DNA replication. They act by inhibiting two key enzymes: **DNA gyrase (Topoisomerase II)** and **Topoisomerase IV**. DNA gyrase is responsible for introducing negative supercoils to relieve the torsional stress ahead of the replication fork. By inhibiting this enzyme, fluoroquinolones cause double-stranded DNA breaks and prevent replication, leading to cell death. In Gram-negative bacteria, DNA gyrase is the primary target, while in Gram-positive bacteria, Topoisomerase IV (which separates daughter chromosomes) is the main target. **Analysis of Incorrect Options:** * **Option A:** Cell wall synthesis inhibition is the mechanism for Beta-lactams (Penicillins, Cephalosporins), Vancomycin, and Bacitracin. * **Option B:** Protein synthesis inhibition is characteristic of Aminoglycosides, Tetracyclines (30S subunit), Macrolides, and Chloramphenicol (50S subunit). * **Option D:** Interference with intermediary metabolism (antimetabolites) describes Sulfonamides and Trimethoprim, which inhibit folic acid synthesis. **High-Yield Clinical Pearls for NEET-PG:** * **Resistance:** Occurs via mutations in the *gyrA* or *parC* genes or through efflux pumps. * **Adverse Effects:** Most characteristic are **tendon rupture/tendonitis** (especially Achilles) and **QT interval prolongation**. * **Contraindications:** Generally avoided in pregnancy and children (due to potential cartilage damage/arthropathy). * **Pharmacokinetics:** Divalent/trivalent cations (Antacids, Iron, Calcium) decrease their absorption.

Question 109: Which of the following cephalosporins has activity against methicillin-resistant Staphylococcus aureus?

A. Ceftriaxone
B. Ceftazidime
C. Cefuroxime
D. Ceftobiprole (Correct Answer)

Explanation: **Explanation:** The correct answer is **Ceftobiprole**. **1. Why Ceftobiprole is correct:** Traditionally, cephalosporins are ineffective against Methicillin-Resistant *Staphylococcus aureus* (MRSA) because they cannot bind to **PBP-2a**, an altered penicillin-binding protein that mediates resistance [1]. **Ceftobiprole** (along with **Ceftaroline**) belongs to the **5th generation cephalosporins**. These agents possess a unique structure that allows high-affinity binding to PBP-2a, thereby inhibiting cell wall synthesis in MRSA strains. **2. Why other options are incorrect:** * **Ceftriaxone (Option A):** A 3rd generation cephalosporin [1] with excellent gram-negative coverage and CNS penetration, but it lacks activity against MRSA. * **Ceftazidime (Option B):** A 3rd generation cephalosporin primarily known for its potent activity against *Pseudomonas aeruginosa* [2]. It has very poor activity against gram-positive organisms like *S. aureus*. * **Cefuroxime (Option C):** A 2nd generation cephalosporin [1] used for respiratory tract infections and surgical prophylaxis. While it covers Methicillin-Sensitive *S. aureus* (MSSA), it is inactivated by the resistance mechanisms of MRSA. **3. High-Yield Clinical Pearls for NEET-PG:** * **5th Generation Duo:** Remember **Ceftaroline** and **Ceftobiprole** as the "MRSA-active cephalosporins." * **Ceftaroline** is the first FDA-approved cephalosporin for MRSA. * **LAME mnemonic:** Cephalosporins generally do **NOT** cover **L**isteria, **A**typicals (Mycoplasma/Chlamydia), **M**RSA (except 5th gen), and **E**nterococci. * **Ceftobiprole** also maintains activity against *Pseudomonas*, whereas Ceftaroline does not.

Question 110: Which of the following statements is not true regarding sulfonamides?

A. Sulfasalazine is poorly absorbed from the GIT. (Correct Answer)
B. Crystalluria can occur with sulfonamide administration.
C. Sulfonamide administration to newborns may cause kernicterus.
D. Sulfonamides are of value in the treatment of infections due to Norcardia species.

Explanation: **Explanation** The question asks for the statement that is **not true**. However, based on pharmacological facts, **Option A is actually a true statement**, making the question technically flawed or implying that the "incorrect" statement is the one to be identified. In medical exams, Sulfasalazine is classically known for its poor oral absorption [2], [3]. **1. Why Option A is the focus:** Sulfasalazine is a prodrug composed of 5-aminosalicylic acid (5-ASA) and sulfapyridine linked by a diazo bond. It is **poorly absorbed from the gastrointestinal tract (GIT)** [2], [3]. This property is therapeutically essential; it allows the drug to reach the colon unchanged, where bacterial enzymes (azoreductases) cleave it to release 5-ASA for local anti-inflammatory action in Ulcerative Colitis and Crohn’s disease. **2. Analysis of other options (All are TRUE statements):** * **Option B (Crystalluria):** Sulfonamides and their acetylated metabolites are relatively insoluble in acidic urine, leading to crystal formation (crystalluria) [3]. Patients are advised to maintain high fluid intake and alkalinize the urine. * **Option C (Kernicterus):** Sulfonamides compete with bilirubin for binding sites on serum albumin. In neonates, this increases free bilirubin, which crosses the blood-brain barrier, leading to encephalopathy (kernicterus). * **Option D (Nocardia):** Sulfonamides (specifically Cotrimoxazole) remain the **drug of choice** for treating infections caused by *Nocardia asteroides* [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Sulfonamides are structural analogs of PABA and inhibit **Dihydropteroate synthase** [1], [3]. * **Mnemonic for Sulfasalazine:** **S**ulfasalazine = **S**tays in gut (Poor absorption) for **S**welling (Inflammation/UC). * **Adverse Effects:** Stevens-Johnson Syndrome (SJS), Hemolysis in G6PD deficient patients, and Phototoxicity. * **Resistance:** Occurs via increased PABA production or altered dihydropteroate synthase enzyme.

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free